Blood Res.  2015 Jun;50(2):118-121. 10.5045/br.2015.50.2.118.

New approaches for cholestasis in hemoglobinopathies

• Dhiman P
• Saxena P
• Bihari C
• Rastogi A
• Sarin SK

• KMID: 2172779
• DOI: http://doi.org/10.5045/br.2015.50.2.118

Abstract

No abstract available.

MeSH Terms

Cholestasis*
Hemoglobinopathies*

Figure

• 

  Fig. 1 Photomicrograph showing inflammatory infiltrate with cholestasis in liver (×400).

• 

  Fig. 2 Photomicrograph showing ballooning of hepatocytes with cholestasis in liver (×400).

Reference

1. Weatherall DJ. Hemoglobinopathies worldwide: present and future. Curr Mol Med. 2008; 8:592–599. PMID: 18991645.

2. Sarnaik SA. Thalassemia and related hemoglobinopathies. Indian J Pediatr. 2005; 72:319–324. PMID: 15876761.

3. Banerjee S, Owen C, Chopra S. Sickle cell hepatopathy. Hepatology. 2001; 33:1021–1028. PMID: 11343226.

4. Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014; 109:950–966. PMID: 24935270.

5. Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology. 2011; 53:1377–1387. PMID: 21480339.

6. Balgir RS. Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Physicians India. 1996; 44:25–28. PMID: 8773089.

7. Mohanty D, Colah RB, Gorakshakar AC, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013; 4:33–42. PMID: 23086467.

8. Ahmed M, Stuhrmann M, Bashawri L, Kühnau W, El-Harith EH. The beta-globin genotype E121Q/W15X (cd121GAA-->CAA/cd15TGG-->TGA) underlines Hb d/beta-(0) thalassaemia marked by domination of haemoglobin D. Ann Hematol. 2001; 80:629–633. PMID: 11757720.

9. Cawein MJ, Lappat EJ, Brangle RW, Farley CH. Hemoglobin S-D disease. Ann Intern Med. 1966; 64:62–70. PMID: 5900784.

10. Papadopoulos V, Karagianni A, Papageorgiou V, et al. Successful management of sickle cell intrahepatic cholestasis with combined use of exchange transfusion and single-pass albumin dialysis: A case report. Open J Blood Dis. 2013; 3:36–42.

11. Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005; 41:1179–1197. PMID: 15841455.

12. Edison ES, Shaji RV, Srivastava A, Chandy M. Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism. Hemoglobin. 2005; 29:189–195. PMID: 16114182.

13. Saritas U, Aydin B, Ustundag Y. Plasmapheresis and corticosteroid treatment for persistent jaundice after successful drainage of common bile duct stones by endoscopic retrograde cholangiography. World J Gastroenterol. 2007; 13:4152–4153. PMID: 17696241.

14. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg. 2001; 234:418–424. PMID: 11524594.

15. Hirschfield GM, Heathcote EJ, Gershwin ME. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 2010; 139:1481–1496. PMID: 20849855.